NK cell-based therapeutics for lung cancer
Author:
Affiliation:
1. John van Geest Cancer Research Centre, Nottingham Trent University, Nottingham, UK
2. Campus Klinikum rechts der Isar, Center for Translational Cancer Research Technische Universität München (TranslaTUM), Munich, Germany
Publisher
Informa UK Limited
Subject
Clinical Biochemistry,Drug Discovery,Pharmacology
Link
https://www.tandfonline.com/doi/pdf/10.1080/14712598.2020.1688298
Reference144 articles.
1. Lung Cancer: Epidemiology, Etiology, and Prevention
2. Molecularly Targeted Therapies in Non–Small-Cell Lung Cancer Annual Update 2014
3. Treatment of ALK-positive nonsmall cell lung cancer: recent advances
4. Making the first move in EGFR-driven or ALK-driven NSCLC: first-generation or next-generation TKI?
5. PD-1 and PD-1 ligands: from discovery to clinical application
Cited by 61 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Metabolic reprogramming and immune evasion: the interplay in the tumor microenvironment;Biomarker Research;2024-09-03
2. LINC00665 promotes the progression and immune evasion of lung cancer by facilitating the translation of TCF7 protein through dependence on IRES;Cancer Cell International;2024-06-29
3. The immune microenvironment of lung adenocarcinoma featured with ground‐glass nodules;Thoracic Cancer;2024-06-24
4. MHC1/LILRB1 axis as an innate immune checkpoint for cancer therapy;Frontiers in Immunology;2024-06-07
5. Immune Cell Migration to Cancer;Cells;2024-05-16
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3